Actin assembly is a crucial factor for superoxide anion generation from adherent human eosinophils

Journal of Allergy and Clinical Immunology

Volumn 112, Issue 1, 2003, Pages 126-133

  Suzuki, Masato ^a   Kato, Masahiko ^a   Hanaka, Hiromi ^a   Izumi, Takashi ^a   Morikawa, Akihiro ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Actin cytoskeleton; Activation; Complement component 5a; Cytochalasin B; Eosinophils; Nicotinamide adenine dinucleotide phosphate oxidase; Platelet activating factor; Protein kinase C; Superoxide anion

Indexed keywords

ACTIN; BETA2 INTEGRIN; CD18 ANTIGEN; COMPLEMENT COMPONENT C5A; CYTOCHALASIN B; CYTOCHALASIN D; CYTOCHROME C; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C ZETA; PROTEIN P47; PROTEIN X; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CALCIUM CELL LEVEL; CELL ACTIVATION; CELL ADHESION; CELL SHAPE; CELL STIMULATION; CYTOSKELETON; DEGRANULATION; EOSINOPHIL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0038337728     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1515     Document Type: Article

References (38)

1. Busse WW, Lemanske RF Jr. Advances in immunology: asthma. N Engl J Med 2001;344:350-62.
2. Leiferman KM. A role for eosinophils in atopic dermatitis. J Am Acad Dermatol 2001;45(suppl):S21-4.
3. Kurtzhals JA, Reimert CM, Tette E, Dunyo SK, Koram KA, Akanmori BD, et al. Increased eosinophil activity in acute plasmodium falciparum infection-association with cerebral malaria. Clin Exp Immunol 1998;112:303-7.
4. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651-63.
5. Patel KD. Eosinophil tethering to interleukin-4-activated endothelial cells requires both P-selectin and vascular cell adhesion molecute-1. Blood 1998;92:3904-11.
6. Lynch OT, Giembycz MA, Berns PJ, Hellewell PG, Lindsay MA. 'Outside-in' signaling mechanisms underlying CD11b/CD18-mediated NADPH oxidase activation in human adherent blood eosinophils. Br J Phrmacol 1999;128:1149-58.
7. Kato M, Abraham RT, Okada S, Kita H. Ligation of the beta-2 integrin triggers activation and degranulation of human eosinophils. Am J Respir Cell Mol Biol 1998;18:675-86.
8. McPhail LC, Waite KA, Regier DS, Nixon JB, Qualliotine-Mann D, Zhang WX, et al. A novel protein kinase target for the lipid second messenger phosphatidic acid. Biochim Biophys Acta 1999;1439:277-90.
9. Someya A, Nishijima K, Nunoi H, Irie S, Nagaoka I. Study on the superoxide-producing enzyme of eosinophils and neutrophils - comparison of the NADPH oxidase components. Arch Biochem Biophys 1997;345:207-13.
10. Bankers-Fulbright JL, Kita H, Gleich GJ, O'Grady SM. Regulation of human eosinophil NADPH oxidase activity: a central role for PKC δ. J Cell Physiol 2001;189:306-15
11. Dekker LV, Leitges M, Altschuler G, Mistry N, McDermott A, Roes J, et al. Protein kinase Cβ contributes to NADPH oxidase activation in neutrophils. Biochem J 2000:347:285-9.
12. Nixon JB, McPhail LC. Protein kinase C (PKC) isoforms translocate to Triton-insoluble fractions in stimulated human neutrophils: correlation of conventional PKC with activation of NADPH oxidase. J Immunol 1999;163:4574-82
13. Tamura M, Kanno M, Endo Y. Deactivation of neutrophil NADPH oxidase by actin-depolymerizing agents in a cell-free system. Biochem J 2000;349:369-75
14. Mukherjee G, Quinn MT, Linner JG, Jesaitis AJ. Remodeling of the plasma membrane after stimulation of neutrophils with f-Met-Leu-Phe and dihydrocytochalasin B: identification of membrane subdomains containing NADPH oxidase activity. J Leukoc Biol 1994;55:685-94.
15. Torres M, Coates TD. Function of the cytoskeleton in human neutrophils and methods for evaluation. J Immunol Methods 1999;232:89-109.
16. Howard TH, Watts RG. Actin polymerization and leukocyte function. Curr Opin Hematol 1994;1:61-8.
17. Pendleton A, Koffer A. Effects of latrunculin reveal requirements for the actin cytoskeleton during secretion from mast cells. Cell Motil Cytoskeleton 2001;48:37-51.
18. 2- production and degranulation. J Leukoc Biol 1991;49:236-44.
19. Granfeldt D, Dahlgren C. An intact cytoskeleton is required for prolonged respiratory burst activity during neutrophil phagocytosis. Inflammation 2001;25:165-9.
20. ++ mobilization and actin reorganization in human eosinophils. Blood 2000;95:973-8.
21. Powell WS, Gravel S, Halwani F. 5-oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of L-selectin shedding, surface expression of CD11b, actin polymerization, and calcium mobilization in human eosinophils. Am J Respir Cell Mol Biol 1999;20:163-70.
22. Ebisawa M, Saito H, Iikura Y. Platelet-activating factor-induced activation and cytoskeletal change in cultured eosinophils. Int Arch Allergy Appl Immunol 1990;93:93-8.
23. 2. Am J Physiol Lung Cell Mol Physiol 2001;281:L844-51.
24. Weber C, Kitayama J, Springer TA. Differential regulation of β1 and β2 integrin avidity by chemoattractants in eosinophils. Proc Natl Acad Sci U S A 1996;93:10939-44.
25. Ide M, Weiler D, Kita H, Gleich GJ. Ammonium chloride exposure inhibits cytokine-mediated eosinophil survival. J Immunol Methods 1994;168:187-96.
26. Kaneko M, Horie S, Kato M, Gleich GJ, Kita H. A crucial role for β2 integrin in the activation of eosinophils stimulated by IgG. J Immunol 1995;155:2631-41.
27. Horie S, Kita H. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor. J Immunol 1994;152:5457-67.
28. Evans DJ, Lindsay MA, Webb BL, Kankaanranta H, Giembycz MA, O'Connor BJ, et al. Expression and activation of protein kinase C in eosinophils after allergen challenge. Am J Physiol 1999;277:L233-9.
29. Kapp A, Zeck-Kapp G, Czech W, Schopf E. The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF. J Invest Dermatol 1994;102:906-14.
30. Takafuji S, Tadokoro K, Ito K, Dahinden CA. Degranulation from human eosinophils stimulated with C3a and C5a. Int Arch Allergy Immunol 1994;104(suppl 1):27-9.
31. Ezeamuzie CI, Philips E. Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release. Br J Pharmacol 1999;127:188-94.
32. Zeck-Kapp G, Kroegel C, Riede UN, Kapp A. Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations. Allergy 1995;50:34-47.
33. Miyamasu M, Hirai K, Takahashi Y, Iida M, Yamaguchi M, Koshino T, et al. Chemotactic agonists induce cytokine generation in eosinophils. J Immunol 1995;154:1339-49.
34. El-Shazly A, Masuyama K, Nakano K, Eura M, Samejima Y, Ishikawa T. Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils. Int Arch Allergy Immunol 1998;117(suppl 1):55-8.
35. Kita H, Abu-Ghazaleh RI, Sur S, Gleich GJ. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils. J Immunol 1995;154:4749-58.
36. Winqvist I, Olofsson T, Olsson I. Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein. Immunology 1984;51:1-8.
37. Walling EA, Krafft GA, Ware BR. Actin assembly activity of cytochalasins and cytochalasin analogs assayed using fluorescence photobleaching recovery. Arch Biochem Biophys 1988;264:321-32.
38. Flanagan MD, Lin S. Cytochalasins block actin filament elongation by binding to high affinity sites associated with f-actin. J Biol Chem 1980;255:835-8.